Rebecca J. Troisi is an American cancer epidemiologist specialized in the hormonal etiologies of reproductive cancers. She is a staff scientist in the trans-divisional research program at the National Cancer Institute.
Rebecca J. Troisi | |
|---|---|
 | |
| Alma mater | Harvard T.H. Chan School of Public Health |
| Scientific career | |
| Fields | Cancer epidemiology |
| Institutions | National Cancer Institute |
Life
editTroisi completed a Sc.D. from the Harvard T.H. Chan School of Public Health in 1994.[1] Her dissertation was titled, Epidemiology of adult-onset asthma.[2] She joined the National Cancer Institute (NCI) the same year.[1] Her research has focused on the hormonal etiologies of reproductive cancers and the role of maternal, gestational, neonatal and early life factors in breast cancer risk, including endocrine disruptors such as diethylstilbestrol, a drug previously given to pregnant women.[1] Troisi and colleagues Marlene Goldman and Kathryn Rexrode edited the second edition of Women and Health, a comprehensive review of the behavioral, social, and biological determinants of health and well-being in women, published in late 2012 by Elsevier.[1] Troisi is a staff scientist in the trans-divisional research program in the NCI division of cancer epidemiology and genetics.[1]
Selected works
edit- Goldman, Marlene B.; Troisi, Rebecca; Rexrode, Kathryn M., eds. (2012). Women and Health (2nd ed.). Elsevier Science. ISBN 978-0-12-384979-3.
References
edit- ^ a b c d e "Rebecca Troisi, Sc.D., biographical sketch and research interests - NCI". dceg.cancer.gov. 2016-09-30. Retrieved 2022-10-16.
This article incorporates text from this source, which is in the public domain.
- ^ Troisi, Rebecca J. (1994). Epidemiology of adult-onset asthma (Sc.D. thesis). Harvard School of Public Health. OCLC 82294816.
This article incorporates public domain material from websites or documents of the National Institutes of Health.